Geoffrey I Hackett (Geoff Hackett, G I Hackett, Geoffrey Hackett, G Hackett)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Benign Prostatic Hyperplasia

Replacement Therapy

Cardiovascular Risk Factors

Angiotensin Converting Enzyme

Top Venues

The world journal of men's health

International journal of clinical practice

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Geoffrey I Hackett, Amar Mann, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Carola S König, Richard C Strange, Sudarshan Ramachandran
Testosterone Replacement Therapy: Effects on Blood Pressure in Hypogonadal Men. The world journal of men's health (2024)
Karim Sultan Haider, Michael Zitzmann, Pravinath Ramachandran, Carola S König, Geoffrey I Hackett, Ahmad Haider, Farid Saad, Pieter Desnerck, Richard C Strange, Amar Mann, Sudarshan Ramachandran
Testosterone therapy over 60 months improves aging male symptoms scores in all men with adult-onset testosterone deficiency. The aging male : the official journal of the International Society for the Study of the Aging Male 27 (1) (2024)
Amar Mann, Richard C Strange, Carola S König, Geoffrey I Hackett, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Sudarshan Ramachandran
Testosterone replacement therapy: association with mortality in high-risk patient subgroups. Andrology (2023)
Amar Mann, Richard C Strange, Carola S König, Geoffrey I Hackett, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Sudarshan Ramachandran
Testosterone replacement therapy: association with mortality in high-risk patient subgroups. Andrology 12 (6) (2023)
Amar Mann, Richard C Strange, Carola S König, Geoffrey I Hackett, Ahmad Haider, Karim Sultan Haider, Pieter Desnerck, Sudarshan Ramachandran
Testosterone replacement therapy: association with mortality in high-risk patient subgroups. Andrology (2023)
Mike Stedman, Martin Brunel Whyte, Mark Lunt, Marco Albanese, Mark Livingston, Roger Gadsby, Geoffrey I Hackett, Simon G Anderson, Adrian H Heald
The treatment rate of erectile dysfunction (ED) in younger men with type 2 diabetes is up to four times higher than the equivalent non-diabetes population. International journal of clinical practice 74 (9) (2020)
Geoffrey I Hackett
Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor? The world journal of men's health 38 (3) (2020)
Mike Stedman, Mark Livingston, Marco Albanese, Geoffrey I Hackett, Adrian H Heald
Hypogonadism is not being sufficiently recognised in 99% of general practices/family doctor surgeries. International journal of clinical practice 74 (2) (2020)
Sudarshan Ramachandran, Geoffrey I Hackett, Richard C Strange
Testosterone replacement therapy: Pre-treatment sex hormone-binding globulin levels and age may identify clinical subgroups. Andrology 8 (5) (2020)
Mark Livingston, Paul Downie, Geoffrey I Hackett, Rachel Marrington, Adrian H Heald, Sudarshan Ramachandran
An audit of the measurement and reporting of male testosterone levels in UK clinical biochemistry laboratories. International journal of clinical practice 74 (11) (2020)
Geoffrey I Hackett, Michael G Kirby
Erectile dysfunction and testosterone deficiency as cardiovascular risk factors? International journal of clinical practice 72 (2) (2018)
Geoffrey I Hackett, Nigel Cole, Akhilesh Mulay, Richard C Strange, Sudarshan Ramachandran
Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function. The world journal of men's health 38 (1) (2018)
Geoffrey I Hackett, Nigel Cole, Akhilesh Mulay, Richard C Strange, Sudarshan Ramachandran
Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU international 123 (3) (2018)
Geoffrey I Hackett
Type 2 Diabetes and Testosterone Therapy. The world journal of men's health 37 (1) (2018)
Sudarshan Ramachandran, R C Strange, A A Fryer, F Saad, Geoffrey I Hackett
The association of sex hormone-binding globulin with mortality is mediated by age and testosterone in men with type 2 diabetes. Andrology 6 (6) (2018)
Geoffrey I Hackett, N Cole, A Saghir, P Jones, R C Strange, S Ramachandran
Testosterone replacement therapy: improved sexual desire and erectile function in men with type 2 diabetes following a 30-week randomized placebo-controlled study. Andrology 5 (5) (2017)